With high costs and similar benefits, use of new neurology drugs is low
MINNEAPOLIS – A number of new neurologic medications for diseases like multiple sclerosis (MS), Parkinson’s disease and migraine have received U.S. Food and Drug Administration (FDA) approval over the past decade.…
You must be logged in to post a comment.